You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 8, August 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (74)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetics
 •Genetic Counseling/ Testing/ Therapy
 •Depression
 •Suicide
 •Alert me on articles by topic

Altered Gene Expression of Brain-Derived Neurotrophic Factor and Receptor Tyrosine Kinase B in Postmortem Brain of Suicide Subjects

Yogesh Dwivedi, PhD; Hooriyah S. Rizavi, MS; Robert R. Conley, MD; Rosalinda C. Roberts, PhD; Carol A. Tamminga, MD; Ghanshyam N. Pandey, PhD

Arch Gen Psychiatry. 2003;60:804-815.

Background  Suicide is a major public health concern. Although authors of many studies have examined the neurobiological aspects of suicide, the molecular mechanisms associated with suicidal behavior remain unclear. Brain-derived neurotrophic factor (BDNF), one of the most important neurotrophins, after binding with and activating receptor tyrosine kinase B (trk B), is directly involved in many physiological functions in the brain, including cell survival and synaptic plasticity. The present study was performed to examine whether the expression of BDNF and/or trk B isoforms was altered in postmortem brain in subjects who commit suicide (hereafter referred to as suicide subjects) and whether these alterations were associated with specific psychopathologic conditions.

Methods  These studies were performed in prefrontal cortex in Brodmann area 9 and hippocampus obtained in 27 suicide subjects and 21 nonpsychiatric control subjects. Levels of messenger RNA and protein levels of BDNF and trk B were determined with competitive reverse transcriptase–polymerase chain reaction and Western blot technique, respectively. The level of neuron-specific enolase messenger RNA as a neuronal marker was also determined in these brain areas.

Results  Messenger RNA levels of BDNF and trk B were significantly reduced, independently and as a ratio to neuron-specific enolase, in both prefrontal cortex and hippocampus in suicide subjects, as compared with those in control subjects. These reductions were associated with significant decreases in the protein levels of BDNF and of full-length trk B but not trk B's truncated isoform. These changes were present in all suicide subjects regardless of psychiatric diagnosis and were unrelated to postmortem interval, age, sex, or pH of the brain.

Conclusions  Given the importance of BDNF in mediating physiological functions, including cell survival and synaptic plasticity, our findings of reduced expression of BDNF and trk B in postmortem brain in suicide subjects suggest that these molecules may play an important role in the pathophysiological aspects of suicidal behavior.


From the Psychiatric Institute, Department of Psychiatry, University of Illinois at Chicago (Drs Dwivedi and Pandey and Ms Rizavi); and the Maryland Psychiatric Research Center, University of Maryland, Baltimore (Drs Conley, Roberts, and Tamminga).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Apolipoprotein E {varepsilon}4 Allele Genotype and the Effect of Depressive Symptoms on the Risk of Dementia in Men: The Honolulu-Asia Aging Study
Irie et al.
Arch Gen Psychiatry 2008;65:906-912.
ABSTRACT | FULL TEXT  

Increased Neurofibrillary Tangles in Patients With Alzheimer Disease With Comorbid Depression
Rapp et al.
AJGP 2008;16:168-174.
ABSTRACT | FULL TEXT  

Differential and brain region-specific regulation of rap-1 and epac in depressed suicide victims.
Dwivedi et al.
Arch Gen Psychiatry 2006;63:639-648.
ABSTRACT | FULL TEXT  

Chronic Antidepressants Potentiate via Sigma-1 Receptors the Brain-derived Neurotrophic Factor-induced Signaling for Glutamate Release
Yagasaki et al.
J. Biol. Chem. 2006;281:12941-12949.
ABSTRACT | FULL TEXT  

Increased Hippocampal Plaques and Tangles in Patients With Alzheimer Disease With a Lifetime History of Major Depression
Rapp et al.
Arch Gen Psychiatry 2006;63:161-167.
ABSTRACT | FULL TEXT  

Transcriptional Profiling of the Developing Rat Brain Reveals That the Most Dramatic Regional Differentiation in Gene Expression Occurs Postpartum
Stead et al.
J. Neurosci. 2006;26:345-353.
ABSTRACT | FULL TEXT  

Reduced hippocampal volumes and memory loss in patients with early- and late-onset depression
Hickie et al.
Br. J. Psychiatry 2005;186:197-202.
ABSTRACT | FULL TEXT  

Relationship of Brain-Derived Neurotrophic Factor and Its Receptor TrkB to Altered Inhibitory Prefrontal Circuitry in Schizophrenia
Hashimoto et al.
J. Neurosci. 2005;25:372-383.
ABSTRACT | FULL TEXT  

Life Stress, Genes, and Depression: Multiple Pathways Lead to Increased Risk and New Opportunities for Intervention
Charney and Manji
Sci Signal 2004;2004:re5-re5.
ABSTRACT | FULL TEXT  

Environmental Enrichment Rescues Protein Deficits in a Mouse Model of Huntington's Disease, Indicating a Possible Disease Mechanism
Spires et al.
J. Neurosci. 2004;24:2270-2276.
ABSTRACT | FULL TEXT  

Suicide and Neuroprotective Genes
JWatch Psychiatry 2003;2003:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.